FDA expands Merck's Ebola vaccine approval to children one year and older
The first FDA-approved Ebola vaccine, dubbed Ervebo, is now available to children as young as one year old, Merck announced today. The approval expands on a 2019 approval of the vaccine for adults.
Europe is also likely on its way to an expanded approval of the vaccine after the European Medicines Agency’s Committee for Medicinal Products for Human Use recommended it, with a final decision expected this quarter.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
